Literature DB >> 16890257

Human fascioliasis infection: gender differences within school-age children from endemic areas of the Nile Delta, Egypt.

Filippo Curtale1, Yehia Abdel Wahab Hassanein, Paolo Barduagni, Mohamed Mostafa Yousef, Aly El Wakeel, Zuhair Hallaj, Santiago Mas-Coma.   

Abstract

Several studies have reported a higher prevalence of infection for human fascioliasis among girls than among boys. To investigate this aspect further a sufficiently large data set was assembled comprising of 21,477 subjects with 932 positive cases. Subjects were primary school children covered by a control programme implemented by the Egyptian Ministry of Health and Population in the Nile Delta from 1988 to 2002. Stool analyses were performed by the Kato-Katz thick smear technique for a quantitative diagnosis on the intensity of infection. Both prevalence and intensity of infection, indirectly measured as mean number of eggs per gram of faeces, were significantly higher among girls than boys. The higher level of infection in girls was consistent across different years and in different survey areas. Co-infection with Schistosoma mansoni was present and associated with fascioliasis, but schistosomiasis was significantly more prevalent among boys. In Egypt rural girls are often involved in household and farm work and are exposed more than boys to infected foci. The lower school attendance for girls in rural areas appears to be an important factor increasing risk of infection. The precise mode of transmission and behavioural risk factors for human infection need to be investigated further to identify those related to gender.

Entities:  

Mesh:

Year:  2006        PMID: 16890257     DOI: 10.1016/j.trstmh.2006.05.006

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Experimental murine fascioliasis derives early immune suppression with increased levels of TGF-β and IL-4.

Authors:  Joon-Yong Chung; Young-An Bae; Doo-Hee Yun; Hyun-Jong Yang; Yoon Kong
Journal:  Korean J Parasitol       Date:  2012-11-26       Impact factor: 1.341

2.  Diagnosis of human fascioliasis in Arusha region, northern Tanzania by microscopy and clinical manifestations in patients.

Authors:  Abdul-Hamid Settenda Lukambagire; Deborah N Mchaile; Mramba Nyindo
Journal:  BMC Infect Dis       Date:  2015-12-23       Impact factor: 3.090

Review 3.  Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control.

Authors:  Maria Alejandra Caravedo; Miguel Mauricio Cabada
Journal:  Res Rep Trop Med       Date:  2020-11-26

4.  Pathogenicity and virulence of the liver flukes Fasciola hepatica and Fasciola Gigantica that cause the zoonosis Fasciolosis.

Authors:  Richard Lalor; Krystyna Cwiklinski; Nichola Eliza Davies Calvani; Amber Dorey; Siobhán Hamon; Jesús López Corrales; John Pius Dalton; Carolina De Marco Verissimo
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Human fascioliasis in Africa: A systematic review.

Authors:  Veronique Dermauw; Joan Muchai; Yara Al Kappany; Ana Lucia Fajardo Castaneda; Pierre Dorny
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

6.  Stunting in pre-school and school-age children in the Peruvian highlands and its association with Fasciola infection and demographic factors.

Authors:  Camille M Webb; Maria Luisa Morales; Martha Lopez; Benicia Baca-Turpo; Eulogia Arque; A Clinton White; Miguel M Cabada
Journal:  PLoS Negl Trop Dis       Date:  2021-06-21

Review 7.  Fascioliasis: An Ongoing Zoonotic Trematode Infection.

Authors:  Mramba Nyindo; Abdul-Hamid Lukambagire
Journal:  Biomed Res Int       Date:  2015-08-31       Impact factor: 3.411

8.  Ectopic Human Fasciola hepatica Infection by an Adult Worm in the Mesocolon.

Authors:  Ah Jin Kim; Chang Hwan Choi; Sun Keun Choi; Yong Woon Shin; Yun-Kyu Park; Lucia Kim; Suk Jin Choi; Jee Young Han; Joon Mee Kim; Young Chae Chu; In Suh Park
Journal:  Korean J Parasitol       Date:  2015-12-31       Impact factor: 1.341

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.